For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Our pandemic obsessions
+Opinion
In print
Our pandemic obsessions
Wednesday 29 September 2021, 10:55 AM

The pandemic’s takeaways are not all about food
Editor Barbara Fountain finds some extreme behaviours have arisen with the COVID-19 pandemic and associated lockdowns
We have learned the art of the elbow bump, the two-metre social distance and the inner-arm sneeze
It seems takeaways are to the end of lockdown w
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.